Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
UPDATE: Novo shares plummet on sales, profit warning for '26
Novo turned in sales and profit growth in 2025 amid an intense obesity market rivalry with Lilly. This year, the company is forecasting declines.
Eric Sagonowsky
,
Fraiser Kansteiner
Feb 4, 2026 9:05am
Top 10 most anticipated drug launches of 2026
Feb 2, 2026 3:00am
Sponsored
Why Innovation Matters in First-Line HER2+ GEA
Feb 2, 2026 8:00am
FDA’s rare pediatric voucher program revived by funding bill
Feb 4, 2026 3:12pm
Sponsored
Why human expertise still matters in AI-driven med comms
Feb 2, 2026 8:00am
Lilly sees big sales increase in 2026 despite pricing pressures
Feb 4, 2026 2:55pm
More News
AbbVie touts Skyrizi, Rinvoq prowess amid J&J IBD competition
Feb 4, 2026 2:52pm
Novartis CEO eyes 2026 growth despite record patent cliff
Feb 4, 2026 2:30pm
BMS lauds Breyanzi's shutout against cancer with soccer legend
Feb 4, 2026 12:25pm
As CEO, Luke Miels wants GSK to be more 'product-centric'
Feb 4, 2026 9:40am
